From groundbreaking findings from the UK Medical Cannabis Registry to clinical trials by the industry’s leading experts, explore the latest advancements in medical cannabis research.
Sleep disorders are thought to affect a significant proportion of the human population, globally. In fact, it is ...
Within humans and other animals, there is a conserved regulatory system of endogenous cannabinoids and receptors call the ...
A 2016 survey of Australian cannabis users found that a majority of respondents were utilising illicit cannabis for ...
The global COVID-19 pandemic has changed the face of countless industries over the last few months – not ...
Chronic pain affects a large proportion of the global population and is often difficult to treat successfully. The ...
There have been a number of studies assessing the use of cannabinoids for acute pain following surgery, yet ...
Studies have shown that several adults diagnosed with Attention-deficit/hyperactivity disorder (ADHD) self-medicate with cannabis products, either in addition ...
In recent years, a number of cannabis-based medicinal products have been investigated for their potential for symptoms associated ...
Dravet Syndrome is a rare childhood epilepsy syndrome that is commonly associated with treatment-resistant epilepsy, despite best medical ...
As medical cannabis products have gained increasing attention throughout the world, and particularly in the UK, perhaps one ...
The cannabinoids from the Cannabis Sativa plant have developed an increasing interest in relation to their medicinal potential. ...
Fibromyalgia is the second most common rheumatologic condition and it is estimated that it affects around 1.5-2 million ...
